MSM PHARMA (0898.538.417): financials and annual accounts

MSM PHARMA

Uccle ·KBO/BCE: BE 0898.538.417

Line	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Balance sheet: assets
`20/58`	919,634	952,346	823,965	811,702	859,737	864,741	889,614	423,529	355,299	372,913	418,735	514,214	542,558	669,088	716,994	6,201	6,201
`21/28`	477,759	530,241	529,767	496,512	530,851	535,023	598,441	96,067	134,402	166,616	203,887	268,005	306,476	374,206	428,926	-	-
`21`	-	-	-	-	-	-	33,050	66,100	99,150	132,200	165,250	198,300	231,350	264,400	297,450	-	-
`22/27`	472,372	524,853	524,379	491,125	525,463	529,635	560,004	24,580	29,865	29,029	33,250	64,318	69,739	104,419	131,476	-	-
`22`	327,589	352,641	377,693	402,746	427,798	452,850	484,293	-	-	-	-	-	-	-	-	-	-
`23`	88,873	101,180	85,803	25,224	28,061	1	813	3,982	5,045	659	467	1,480	149	224	298	-	-
`24`	52,307	71,032	60,883	63,155	69,604	76,784	74,898	20,598	24,820	28,370	32,783	62,837	69,590	104,195	131,178	-	-
`27`	3,604	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`28`	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	5,387	-	-	-
`29/58`	441,875	422,106	294,198	315,190	328,886	329,718	291,173	327,462	220,897	206,297	214,848	246,209	236,081	294,882	288,068	6,201	6,201
`29`	-	50,000	50,000	50,000	50,000	-	-	-	-	-	-	-	-	-	-	-	-
`291`	-	50,000	50,000	50,000	50,000	-	-	-	-	-	-	-	-	-	-	-	-
`3`	147,798	111,464	115,862	84,574	103,633	134,899	132,222	117,972	87,532	67,550	84,391	104,968	99,693	121,827	95,926	-	-
`30/36`	147,798	111,464	115,862	84,574	103,633	134,899	132,222	117,972	87,532	67,550	84,391	104,968	99,693	121,827	95,926	-	-
`40/41`	164,215	145,211	79,694	60,973	83,271	170,963	117,256	182,364	101,043	98,322	101,156	124,572	125,839	140,520	171,700	6,201	6,201
`40`	34,883	19,909	47,608	40,650	53,825	52,966	23,328	114,123	34,123	34,151	50,339	22,939	46,815	32,726	21,139	-	-
`41`	129,332	125,303	32,086	20,323	29,446	117,997	93,927	68,241	66,919	64,171	50,817	101,633	79,024	107,794	150,560	6,201	6,201
`50/53`	500	500	1,100	6,100	5,600	5,600	5,000	5,000	5,000	-	-	-	-	-	-	-	-
`54/58`	126,267	113,177	46,369	113,253	83,125	16,979	24,997	21,565	26,061	39,102	29,301	16,669	9,347	28,622	15,963	-	-
`490/1`	3,094	1,753	1,174	290	3,257	1,277	11,697	560	1,261	1,323	-	-	1,203	3,913	4,479	-	-
Balance sheet: equity and liabilities
`10/49`	919,634	952,346	823,965	811,702	859,737	864,741	889,614	423,529	355,299	372,913	418,735	514,214	542,558	669,088	716,994	6,201	6,201
`10/15`	230,323	108,624	20,702	-25,711	-100,887	-135,424	-135,774	-132,082	-160,085	-214,579	-269,228	-204,965	-173,524	-117,180	-4,397	6,200	6,200
`10/11`	6,200	6,200	6,200	6,200	6,200	-	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200	6,200
`100`	-	-	-	-	-	-	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600	18,600
`101`	-	-	-	-	-	-	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400	12,400
`11`	-	-	-	-	-	6,200	-	-	-	-	-	-	-	-	-	-	-
`1100/10`	-	-	-	-	-	6,200	-	-	-	-	-	-	-	-	-	-	-
`13`	65,000	25,000	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
`133`	65,000	25,000	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
`14`	159,123	77,424	14,502	-31,911	-107,087	-141,624	-141,974	-138,282	-166,285	-220,779	-275,428	-211,165	-179,724	-123,380	-10,597	-	-
`16`	-	-	-	5,000	5,000	5,000	5,000	5,000	-	-	-	-	-	-	-	-	-
`160/5`	-	-	-	5,000	5,000	5,000	5,000	5,000	-	-	-	-	-	-	-	-	-
`163`	-	-	-	5,000	5,000	5,000	5,000	5,000	-	-	-	-	-	-	-	-	-
`17/49`	689,311	843,723	803,263	832,413	955,623	995,166	1.0m	550,611	515,385	587,492	687,964	719,179	716,081	786,268	721,391	0	0
`17`	363,848	488,245	524,216	608,694	724,802	780,902	820,256	276,754	319,150	353,224	390,249	431,361	473,088	513,513	547,473	-	-
`170/4`	363,848	454,396	490,367	580,050	677,612	733,712	820,256	276,754	319,150	353,224	390,249	431,361	473,088	513,513	547,473	-	-
`175`	-	33,849	33,849	28,644	47,190	47,190	-	-	-	-	-	-	-	-	-	-	-
`42/48`	324,450	353,604	277,282	222,343	229,254	212,573	197,128	272,922	195,190	229,841	295,128	283,701	238,877	272,756	173,918	-	-
`42`	99,145	125,109	103,627	97,563	88,165	92,802	90,120	45,576	44,342	39,986	43,975	41,215	40,552	43,541	70,978	-	-
`43`	45,000	44,000	24,000	-	-	-	-	61,312	9,227	9,227	9,227	26,827	-	-	-	-	-
`430/8`	45,000	44,000	24,000	-	-	-	-	61,312	9,227	9,227	9,227	26,827	-	-	-	-	-
`44`	109,320	89,675	88,996	65,739	101,932	89,745	62,710	124,283	125,659	155,245	220,385	197,935	178,666	203,052	98,598	-	-
`440/4`	109,320	89,675	88,996	65,739	101,932	89,745	62,710	124,283	125,659	155,245	220,385	197,935	178,666	203,052	98,598	-	-
`46`	21,869	22,357	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
`45`	49,116	30,633	60,658	59,041	33,706	17,995	16,819	14,067	6,915	8,810	21,540	17,724	19,660	26,163	4,342	-	-
`450/3`	33,230	11,903	44,263	39,508	17,787	7,910	6,205	5,183	1,240	2,137	11,583	6,619	5,026	16,339	428	-	-
`454/9`	15,886	18,730	16,395	19,533	15,919	10,085	10,614	8,884	5,675	6,673	9,957	11,105	14,634	9,823	3,914	-	-
`47/48`	-	41,830	-	-	5,451	12,031	27,480	27,683	9,048	16,573	-	-	-	-	-	-	-
`492/3`	1,012	1,874	1,766	1,376	1,567	1,691	3,004	935	1,045	4,427	2,587	4,116	4,116	-	-	0	0
Income statement
`70`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	726,518	-	-
`76A`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	473	-	-
`9900`	353,960	315,630	291,037	282,616	215,329	190,439	242,799	143,675	138,714	147,029	89,767	127,188	108,767	110,737	118,410	0	0
`60/61`	-	-	-	-	-	-	-	-	-	-	-	-	-	-	608,108	0	-
`62`	84,117	97,206	132,409	102,608	95,519	71,841	56,482	48,184	27,963	33,654	50,739	59,356	60,839	76,062	28,540	-	-
`630`	58,883	58,132	51,039	45,650	40,851	79,014	157,010	40,770	40,177	38,259	70,747	72,863	70,995	69,962	66,516	-	-
`635/8`	-	-	-	-	-	-	-	5,000	-	-	-	-	-	-	-	-	-
`640/8`	2,782	2,671	19	180	6	1,069	269	217	231	506	0	1,701	894	892	2,231	-	-
`66A`	-	-	-	-	-	-	-	-	-	-	-	-	5,213	4,694	12,483	-	-
`9901`	208,179	157,621	107,570	134,178	78,953	38,515	29,037	49,504	70,344	74,610	-31,720	-6,733	-23,962	-36,179	21,123	0	0
`75/76B`	2,329	166	1,404	967	-	788	2,408	759	12	681	182	7,588	25	231	141	-	4
`75`	2,329	166	1,404	967	-	788	2,408	759	12	681	182	7,588	25	231	141	-	4
`65/66B`	26,610	25,821	23,736	30,287	29,628	31,140	32,408	16,238	15,636	20,417	32,319	32,163	27,194	28,981	19,851	-	3
`65`	26,610	25,821	23,736	30,287	29,628	31,140	32,408	16,238	15,636	20,417	32,319	32,163	27,194	28,981	19,851	-	3
`9903`	183,898	131,967	85,238	104,858	49,324	8,163	-963	34,024	54,719	54,874	-63,857	-31,307	-56,344	-69,623	-10,597	0	1
`67/77`	62,198	44,045	38,825	29,682	14,787	7,813	2,729	6,022	225	225	406	134	-	-	0	-	1
`9904`	121,699	87,922	46,412	75,176	34,537	350	-3,692	28,003	54,494	54,649	-64,263	-31,441	-56,344	-69,623	-10,597	0	0
`9905`	121,699	87,922	46,412	75,176	34,537	350	-3,692	28,003	54,494	54,649	-64,263	-31,441	-56,344	-69,623	-10,597	0	0
Appropriation of the result
`9906`	199,123	102,424	14,502	-31,911	-107,087	-141,624	-141,974	-138,282	-166,285	-220,779	-275,428	-211,165	-179,724	-123,380	-10,597	0	0
`14P`	77,424	14,502	-31,911	-107,087	-	-	-	-	-	-	-	-	-	-	-	-	-
`691/2`	40,000	25,000	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
`6921`	40,000	25,000	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Social balance sheet
`9087`	2.8	2.4	2.7	2	1.9	1.6	1.5	1.3	0.8	1	2	2.1	1.7	2.5	1.4	-	-
Hours worked`1013`	4,639	4,078	4,793	3,639	3,303	2,826	2,746	1,972	1,564	1,861	3,124	3,996	3,413	3,692	1,445	-	-
Document	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF	PDF

Financial year	Type	Filed	Reference	Document
30-06-2025	full format	28-01-2026	2026-00015911	PDF
30-06-2024	full format	31-01-2025	2025-00022239	PDF
30-06-2023	full format	08-02-2024	2024-00029445	PDF
30-06-2022	full format	05-06-2023	2023-00111553	PDF
30-06-2021	full format	21-03-2022	2022-08200278	PDF
30-06-2020	full format	31-01-2021	2021-04100558	PDF
30-06-2019	full format	10-01-2020	2020-00800334	PDF
30-06-2018	full format	30-01-2019	2019-03300283	PDF
30-06-2017	full format	31-01-2018	2018-03800155	PDF
30-06-2016	full format	06-03-2017	2017-05800506	PDF
30-06-2015	full format	28-12-2016	2016-71900123	PDF
30-06-2014	full format	17-02-2015	2015-04400309	PDF
30-06-2013	full format	06-05-2014	2014-11800600	PDF
30-06-2012	full format	06-05-2014	2014-11800599	PDF
30-06-2011	full format	27-02-2012	2012-04800490	PDF
30-06-2010	full format	25-02-2011	2011-04500531	PDF
30-06-2009	full format	25-02-2011	2011-04500548	PDF

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
267,062	215,753	158,609	179,828	119,804	117,529	186,048	90,274	110,520	112,869	39,028	66,131	47,034	33,783	87,640	-	-
180,582	146,054	97,451	120,826	75,389	79,364	153,318	68,773	94,671	92,908	6,484	41,422	14,652	340	55,919	-	-
6,401	60,900	84,293	11,311	36,679	15,595	659,384	2,435	7,962	987	6,630	34,392	3,266	15,242	495,443	-	-
13,090	66,809	-66,884	30,128	66,146	-8,018	3,432	-4,496	-13,041	9,801	12,632	7,322	-19,276	12,659	-	-	-
117,424	68,502	16,917	92,847	99,632	117,146	94,044	54,540	25,708	-23,544	-80,280	-37,493	-2,796	22,127	114,150	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.9%	-	-
25.0%	11.4%	2.5%	-3.2%	-11.7%	-15.7%	-15.3%	-31.2%	-45.1%	-57.5%	-64.3%	-39.9%	-32.0%	-17.5%	-0.6%	100.0%	100.0%
1.36	1.19	1.06	1.42	1.43	1.55	1.48	1.20	1.13	0.90	0.73	0.87	0.99	1.08	1.66	-	-
0.91	0.88	0.64	1.04	0.98	0.92	0.81	0.77	0.68	0.60	0.44	0.50	0.57	0.63	1.10	-	-
2.99	7.77	38.80	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00
52.8%	80.9%	224.2%	-	-	-	-	-	-	-	-	-	-	-	-	0.0%	0.0%
13.2%	9.2%	5.6%	9.3%	4.0%	0.0%	-0.4%	6.6%	15.3%	14.7%	-15.3%	-6.1%	-10.4%	-10.4%	-1.5%	0.0%	0.0%
10.04	8.36	6.68	5.94	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	11 days	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	59 days	-	-

Item	30-06-2025	30-06-2024	30-06-2023	30-06-2022
Employees at the balance-sheet date	4	3	3	3
full-time	2	1	1	-
part-time	2	2	2	3
in full-time equivalents	2.2	1.7	2.3	2.2
	2.8	2.4	2.7	2
On a permanent contract	2	2	3	2
Joined	6	4	-	6
Left	5	4	-	7

Item	30-06-2025	30-06-2024	30-06-2023	30-06-2022
Tangible fixed assets	€6,401	€60,900	€84,293	€11,311
	€58,883	€58,132	€51,039	€45,650

MSM PHARMA

Annual accounts 2025

Money flows

Balance sheet

in euro

in euro

Position in the sector

25.0%

1.36

13.2%

Staff

€30,042

+1 person

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on MSM PHARMA

Next steps

Annual accounts 2025

Money flows

Balance sheet

Change in equityin euro

Change in cashin euro

Position in the sector

Solvency25.0%

Current ratio1.36

Return on assets13.2%

Staff

Staff cost per FTE€30,042

Joined and left+1 person

Filed annual accounts

Filings

Key figures and ratios

Social balance sheet

Investments

Insights on MSM PHARMA

Next steps

in euro

in euro

25.0%

1.36

13.2%

€30,042

+1 person